FORM-2C (Frequency of Renal Monitoring – Creatinine and Cystatin C): an observational cohort study of primary care patients with reduced eGFR
<p><strong>Background:</strong> Monitoring is the mainstay of chronic kidney disease management in primary care. There is little evidence on how best to monitor.</p> <p><strong>Aim:</strong> To compare the effectiveness of eGFR derived from creatinine or cy...
Main Authors: | Fleming, S, Perera-Salazar, R, Taylor, K, Jones, L, Hobbs, FDR, james, T, O'callaghan, C, Shine, B, verbackel, J, Stevens, R, Bankhead, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Royal College of General Practitioners
2021
|
Similar Items
-
Questionable Validity of Creatinine-Based eGFR in Elderly Patients but Cystatin C Is Helpful in First-Line Diagnostics
by: Dario Geißer, et al.
Published: (2023-12-01) -
Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank
by: Debbie C. Chen, et al.
Published: (2024-04-01) -
Should Cystatin C eGFR Become Routine Clinical Practice?
by: Sebastian Spencer, et al.
Published: (2023-07-01) -
Relationships between cystatin C and creatinine‐based eGFR with low tongue pressure in Japanese rural community‐dwelling older adults
by: Hiroshi Kusunoki, et al.
Published: (2022-10-01) -
Estimating eGFR using Serum Cystatin C alone and in combination with Serum Creatinine: A Prospective study in individuals with CKD in north Telangana
by: B Venugopal1 , S Sangeeta2
Published: (2018-08-01)